Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Stock Option Activity (Detail)

v3.22.2
Stockholders' Equity - Stock Option Activity (Detail)
6 Months Ended 12 Months Ended
May 31, 2022
USD ($)
$ / shares
shares
Nov. 30, 2021
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted 52,500  
Service-Based Vesting Condition Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding at November 30, 2021 537,443  
Granted 52,500  
Exercised (10,000)  
Expired/forfeited (84,000)  
Outstanding at May 31, 2022 495,943 537,443
Exercisable at May 31, 2022 399,029  
Outstanding at November 30, 2021, Weighted Average Exercise Price | $ / shares $ 5.76  
Granted, Weighted Average Exercise Price | $ / shares 13.20  
Exercised, Weighted Average Exercise Price | $ / shares 3.20  
Expired/forfeited, Weighted Average Exercise Price | $ / shares 6.07  
Outstanding at May 31, 2022, Weighted Average Exercise Price | $ / shares 6.54 $ 5.76
Exercisable at May 31, 2022, Weighted Average Exercise Price | $ / shares $ 5.39  
Outstanding, Weighted Average Remaining Contractual Term (Years) 4 years 5 months 26 days 5 years 2 months 19 days
Exercisable at May 31, 2022, Weighted Average Remaining Contractual Term (Years) 4 years 6 months 7 days  
Outstanding at November 30, 2021, Aggregate Intrinsic Value | $ $ 3,564,067  
Exercised, Aggregate Intrinsic Value | $ 87,000  
Expired/forfeited, Aggregate Intrinsic Value | $ 112,875  
Outstanding at May 31, 2022, Aggregate Intrinsic Value | $ 626,540 $ 3,564,067
Exercisable at May 31, 2022, Aggregate Intrinsic Value | $ $ 626,540